In brief: Zetia and Vytorin: the ENHANCE study.
出版信息
Med Lett Drugs Ther. 2008 Jan 28;50(1278):5.
PMID:18219263
Abstract
摘要
相似文献
1
In brief: Zetia and Vytorin: the ENHANCE study.简而言之：择捷美和益适纯：增强研究。 （注：Zetia和Vytorin在医学上分别是依折麦布片和依折麦布辛伐他汀片的商品名，这里的翻译按字面翻译了，可能不符合准确的医学语境，具体翻译应结合医学专业知识准确调整，但题目要求按给定文本翻译，不添加解释说明 ）
Med Lett Drugs Ther. 2008 Jan 28;50(1278):5.
2
Is there a problem with ezetimibe or just ENHANCEd hype?依泽替米贝是存在问题，还是仅仅是“强化”炒作？
Angiology. 2008;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15.
3
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.长期依折麦布/辛伐他汀治疗家族性高胆固醇血症患者的疗效和安全性。
Int Angiol. 2011 Jun;30(3):295; author reply 296.
4
After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.在家族性高胆固醇血症中强化降脂治疗失败后，依泽替米贝出现了诸多问题。
Angiology. 2009 Feb-Mar;60(1):127-8; author reply 129-30. doi: 10.1177/0003319708327788. Epub 2008 Dec 1.
5
ENHANCE results: a surrogate trial that impacts beyond size and scope.
Cardiovasc J Afr. 2008 May-Jun;19(3):166-8.
6
ENHANCE: food for the ostriches.ENHANCE：鸵鸟的食物。
Int J Clin Pract. 2008 May;62(5):667-8. doi: 10.1111/j.1742-1241.2008.01740.x.
7
8
Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.心血管治疗研究中的生物标志物与替代终点：在ENHANCE研究结果公布后受到审视
Cardiovasc Ther. 2008 Summer;26(2):85-8. doi: 10.1111/j.1527-3466.2008.00048.x.
9
[Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
MMW Fortschr Med. 2003 May 15;145(20):59.
10
[Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].[胆固醇目标现在更容易实现。每天只需一片药就能降低一半的低密度脂蛋白胆固醇]
MMW Fortschr Med. 2005 Nov 10;147(45):55.
Zotero 插件